Antifungals and Resistance
- Submission status
- Open
- Submission deadline
The Fungal Kingdom includes a phenomenal diversity of organisms, some of which pose devastating threats to agriculture, human health, and biodiversity. There is a limited number of antifungal agents, and the emergence of resistance threatens the efficacy of existing antifungals. There is an urgent need for new strategies to thwart emerging and resistant fungal pathogens alongside the need for greater understanding of one-health aspects. This collection aims to publish cutting-edge research on methods to mitigate fungal infections and to combat the emergence of resistance.
Diverse topics will be covered, including:
- Current antifungals used in medicine, agriculture, and animal husbandry
- Mechanisms enabling the evolution of resistance to antifungal agents
- Emergence of resistance to antifungals in the environment and the clinic
- Reservoirs of antifungal resistance
- Effects of antifungals on microbiomes
- Microbiomes as sources of new antifungals
- Approaches for discovery of new antifungals
- Identifying targets of new antifungals
- Antifungal combinations and synergy
- Antifungal stewardship
- Policy aspects of antifungal development and usage
This Collection supports and amplifies research related to SDG 3.
Editors
-
Matthew Fisher
Professor of Fungal Disease Epidemiology, Faculty of Medicine, School of Public Health, Imperial College London, UK
-
Leah Cowen
University of Toronto Toronto, ON, Canada
All articles have undergone npj Antimicrobial and Resistance's standard peer review process and have been subject to all the journal’s standard policies. This includes the journal’s policy on competing interests. The Editors declare no competing interests with the submissions which they have handled through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
If accepted for publication, an article processing charge applies (with standard waiver policy). If your institution or country has an open access agreement with Springer Nature, you may publish your article OA at no cost or in some cases with the costs partially funded (see details here).
All Collections are open for submissions from all authors – and not by invitation only – on the condition that the manuscripts fall within the scope of the Collection and of npj Antimicrobial and Resistance more generally.
Manuscripts submitted to an open Collection may be considered unsuitable for inclusion, particularly if they fall outside the scope of the Collection. In such cases, the authors will be notified by the editorial office and their manuscript can be considered as a regular npj Antimicrobial and Resistance submission.
npj Antimicrobial and Resistance’s in-house editors reserve the right to assume responsibility for the management of a Collection at any stage.
